I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InDex Pharmaceuticals Holding AB
Other Current Liabilities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Other Current Liabilities
kr10.8m
CAGR 3-Years
112%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Other Current Liabilities
kr26.6m
CAGR 3-Years
44%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Other Current Liabilities
kr114.7m
CAGR 3-Years
67%
CAGR 5-Years
59%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Other Current Liabilities
kr120.3m
CAGR 3-Years
56%
CAGR 5-Years
80%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Other Current Liabilities
kr8.4m
CAGR 3-Years
30%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Other Current Liabilities
kr3.3m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Other Current Liabilities?
Other Current Liabilities
10.8m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Other Current Liabilities amounts to 10.8m SEK.

What is InDex Pharmaceuticals Holding AB's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
73%

Over the last year, the Other Current Liabilities growth was 900%. The average annual Other Current Liabilities growth rates for InDex Pharmaceuticals Holding AB have been 112% over the past three years , 73% over the past five years .

Back to Top